Evidence map›Paper›PMID 38030892›Full record

ArticleAnnals of hematology2024

Appropriate timing to perform an interim

Rang Wang, Yue Zhang, Qiuping Fan, Ming Jiang, Liqun Zou, Minggang Su

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of hematology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 citations in OpenAlex.

  1. Prognostic value of lesion dissemination onQuantitative imaging in medicine and surgery · 2026
    Article
  2. Review
  3. Article
  4. The role ofFrontiers in oncology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rang Wang *Department of Nuclear Medicine, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610041, Sichuan, China.
Yue Zhang *Department of Nuclear Medicine, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610041, Sichuan, China.
Qiuping FanDepartment of Nuclear Medicine, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610041, Sichuan, China.
Ming JiangDepartment of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610041, Sichuan, China.
Liqun ZouDepartment of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610041, Sichuan, China.
Minggang SuDepartment of Nuclear Medicine, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610041, Sichuan, China. suminggang@sina.com.
Sichuan University · CNWest China Hospital of Sichuan University · CN

Funding

the Post-Doctor Research Project, West China Hospital, Sichuan University 2023HXBH075
6 · The paper itself

Abstract

Interim

Indexed as

Lymphoma, Extranodal NK-T-CellFluorodeoxyglucose F18HumansKiller Cells, NaturalPositron Emission Tomography Computed TomographyPrognosisRetrospective StudiesFluorodeoxyglucose F1818F-FDG PET/CTAppropriate timingExtranodal natural killer/T cell lymphomaResponse evaluation

Identifiers

PMID38030892
OpenAlexW4389153544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.